Provided by Tiger Fintech (Singapore) Pte. Ltd.

Candel Therapeutics, Inc.

8.75
+0.810010.20%
Post-market: 8.750.00000.00%19:59 EDT
Volume:1.02M
Turnover:8.70M
Market Cap:413.31M
PE:-5.03
High:8.79
Open:7.96
Low:7.96
Close:7.94
Loading ...

Sector Update: Health Care Stocks Edge Higher Late Afternoon

MT Newswires Live
·
14 Dec 2024

Update: Candel Therapeutics Prices $80 Million Public Offering -- Shares Fall

MT Newswires Live
·
14 Dec 2024

Top Midday Decliners

MT Newswires Live
·
14 Dec 2024

Sector Update: Health Care Stocks Steady Premarket Friday

MT Newswires Live
·
13 Dec 2024

Investors Look to End Week on Strong Note as US Futures Rise in Friday's Premarket

MT Newswires Live
·
13 Dec 2024

Candel Therapeutics Shares Fall Premarket After Public Offering

Dow Jones
·
13 Dec 2024

BRIEF-Candel Therapeutics Prices Public Offering Of 10,000,001 Shares Of Common Stock At $6.00 Per Share

Reuters
·
13 Dec 2024

Candel Therapeutics Announces Pricing of Public Offering

THOMSON REUTERS
·
13 Dec 2024

BUZZ-Candel Therapeutics slides after launching $80 mln stock offering

Reuters
·
13 Dec 2024

Candel Therapeutics Shares Down 20.7% After the Bell; Announces $80 Mln Proposed Public Offering

THOMSON REUTERS
·
13 Dec 2024

Candel Therapeutics announces $80M common stock offering

TIPRANKS
·
13 Dec 2024

Candel Therapeutics Announces $80 Million Proposed Public Offering

THOMSON REUTERS
·
13 Dec 2024

Candel Therapeutics Inc: Intends to Grant Underwriters a 30-Day Option to Purchase up to an Additional $12 Mln of Shares of Its Common Stock Offered

THOMSON REUTERS
·
13 Dec 2024

Press Release: Candel Therapeutics Announces $80 Million Proposed Public Offering

Dow Jones
·
13 Dec 2024

CADL Stock Soars as Phase III Prostate Cancer Study Meets Primary Goal

Zacks
·
12 Dec 2024

Candel Therapeutics Prostate Cancer Therapy Shows Promise

Exec Edge
·
12 Dec 2024